These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 687216)

  • 1. Prognostic importance of the tumor-free laryngectomy specimen.
    Weymuller EA
    Arch Otolaryngol; 1978 Sep; 104(9):505-7. PubMed ID: 687216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of laryngeal cancer.
    Bryce DP
    J Otolaryngol; 1979 Apr; 8(2):105-26. PubMed ID: 430578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typical laryngeal carcinoid tumor with recurrence and lymph node metastasis: a case report and review of the literature.
    Wang Q; Chen H; Zhou S
    Int J Clin Exp Pathol; 2014; 7(12):9028-31. PubMed ID: 25674282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronal sections of larynges from radiation-therapy failures: a clinical-pathologic study.
    Brandenburg JH; Condon KG; Frank TW
    Otolaryngol Head Neck Surg; 1986 Sep; 95(2):213-8. PubMed ID: 3108762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dosage preoperative radiation and surgery for carcinoma of the larynx and laryngopharynx.
    Goldman JL; Roffman JD; Zak FG; Birken EA
    Ann Otol Rhinol Laryngol; 1972 Aug; 81(4):488-95. PubMed ID: 5055081
    [No Abstract]   [Full Text] [Related]  

  • 7. Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx.
    Kligerman J; Olivatto LO; Lima RA; Freitas EQ; Soares JR; Dias FL; Melo LE; Sá GM; Duccini E
    Am J Surg; 1995 Nov; 170(5):436-9. PubMed ID: 7485727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parastomal tumors after laryngectomy: etiology and therapy].
    Metternich FU; Brusis T
    Laryngorhinootologie; 1997 Feb; 76(2):88-95. PubMed ID: 9172635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The histological study of adenopathies in laryngeal cancer with supraglottic localization].
    Barona R; Martorell MA; Basterra J; Armengot M; Montalt J
    Acta Otorrinolaringol Esp; 1994; 45(4):255-9. PubMed ID: 7917476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is elective neck dissection necessary in cases of laryngeal recurrence after previous radiotherapy for early glottic cancer?
    Deganello A; Meccariello G; Bini B; Paiar F; Santoro R; Mannelli G; Gallo O
    J Laryngol Otol; 2014 Dec; 128(12):1089-94. PubMed ID: 25418930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence after radiotherapy for glottic carcinoma.
    Viani L; Stell PM; Dalby JE
    Cancer; 1991 Feb; 67(3):577-84. PubMed ID: 1898708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphatic drainage of the larynx--effect on therapeutic decision in larynx carcinoma].
    Hagen R
    HNO; 1996 Feb; 44(2):55-60. PubMed ID: 8852800
    [No Abstract]   [Full Text] [Related]  

  • 14. The prognostic value of proliferating cell nuclear antigen (PCNA) in the advanced cancer of larynx.
    Dobroś W; Ryś J; Niezabitowski A; Olszewski E
    Auris Nasus Larynx; 1998 Sep; 25(3):295-301. PubMed ID: 9799997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T3 laryngeal cancer, primary surgery vs planned combined radiotherapy and surgery.
    Tjho-Heslinga RE; Terhaard CH; Schouwenburg P; Hilgers FJ; Dolsma WV; Croll GA; Hoogenhout J; Knegt PP; Leer JW; Hordijk GJ
    Clin Otolaryngol Allied Sci; 1993 Dec; 18(6):536-40. PubMed ID: 8877237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The frequency and prognosis of lymphadenopathy secondary to carcinoma of the larynx (author's transl)].
    André P; Laccourreye H; Haguet JF; Frachet B
    Ann Otolaryngol Chir Cervicofac; 1977 Jun; 94(6):291-300. PubMed ID: 911123
    [No Abstract]   [Full Text] [Related]  

  • 18. [The influence of selected clinical and morphological factors on treatment results of patients with advanced cancer of the larynx].
    Miśkiewicz-Orczyk K; Namysłowski G; Misiołek M; Majewski W
    Otolaryngol Pol; 2013; 67(1):34-9. PubMed ID: 23374662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Topographical and clinico-oncologic analysis of locoregional recurrence after transoral laser surgery for laryngeal cancer].
    Eckel HE
    Laryngorhinootologie; 1993 Aug; 72(8):406-11. PubMed ID: 8397594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer of the larynx and 5 years survival].
    Merino E; Hellín D; Amorós LM; Pernas J; Jiménez-Cervantes J
    An Otorrinolaringol Ibero Am; 1994; 21(4):357-68. PubMed ID: 8092443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.